Abstract
Summary
Exosomes are small vesicles secreted by cells, which contain biomolecules such as proteins, nucleic acids, and lipids. In recent years, exosomes have attracted much attention due to their role in intercellular communication, disease occurrence and development, etc. The application of exosomes in treatment and diagnosis has also gradually attracted attention.
The global Exosome Therapeutics and Diagnostics market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LPI (LP Information)' newest research report, the “Exosome Therapeutics and Diagnostics Industry Forecast” looks at past sales and reviews total world Exosome Therapeutics and Diagnostics sales in 2022, providing a comprehensive analysis by region and market sector of projected Exosome Therapeutics and Diagnostics sales for 2023 through 2029. With Exosome Therapeutics and Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Exosome Therapeutics and Diagnostics industry.
This Insight Report provides a comprehensive analysis of the global Exosome Therapeutics and Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Exosome Therapeutics and Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Exosome Therapeutics and Diagnostics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Exosome Therapeutics and Diagnostics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Exosome Therapeutics and Diagnostics.
United States market for Exosome Therapeutics and Diagnostics is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Exosome Therapeutics and Diagnostics is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Exosome Therapeutics and Diagnostics is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Exosome Therapeutics and Diagnostics players cover Evox Therapeutics, Carmine Therapeutics, Exopharm, Aruna Bio, Capricor Therapeutics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Exosome Therapeutics and Diagnostics market by product type, application, key players and key regions and countries.
Segmentation by Type:
Treatment
Diagnosis
Segmentation by Application:
Cancer
Neurological Diseases
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Segmentation by Type:
Treatment
Diagnosis
Segmentation by Application:
Cancer
Neurological Diseases
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Evox Therapeutics
Carmine Therapeutics
Exopharm
Aruna Bio
Capricor Therapeutics
Mantra Bio
Adipomics
ReNeuron
Aegle Therapeutics
Sarepta Therapeutics
Codiak Biosciences
Exosomics
Innocan Pharma
Aethlon Medical
ExoCoBio
Organicell
Puretech
Versatope
Vesvigen Therapeutics
Exosome Plus
Exosome Diagnostics
ECHO Biaotech
The global Exosome Therapeutics and Diagnostics market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LPI (LP Information)' newest research report, the “Exosome Therapeutics and Diagnostics Industry Forecast” looks at past sales and reviews total world Exosome Therapeutics and Diagnostics sales in 2022, providing a comprehensive analysis by region and market sector of projected Exosome Therapeutics and Diagnostics sales for 2023 through 2029. With Exosome Therapeutics and Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Exosome Therapeutics and Diagnostics industry.
This Insight Report provides a comprehensive analysis of the global Exosome Therapeutics and Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Exosome Therapeutics and Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Exosome Therapeutics and Diagnostics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Exosome Therapeutics and Diagnostics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Exosome Therapeutics and Diagnostics.
United States market for Exosome Therapeutics and Diagnostics is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Exosome Therapeutics and Diagnostics is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Exosome Therapeutics and Diagnostics is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Exosome Therapeutics and Diagnostics players cover Evox Therapeutics, Carmine Therapeutics, Exopharm, Aruna Bio, Capricor Therapeutics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Exosome Therapeutics and Diagnostics market by product type, application, key players and key regions and countries.
Segmentation by Type:
Treatment
Diagnosis
Segmentation by Application:
Cancer
Neurological Diseases
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Segmentation by Type:
Treatment
Diagnosis
Segmentation by Application:
Cancer
Neurological Diseases
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Evox Therapeutics
Carmine Therapeutics
Exopharm
Aruna Bio
Capricor Therapeutics
Mantra Bio
Adipomics
ReNeuron
Aegle Therapeutics
Sarepta Therapeutics
Codiak Biosciences
Exosomics
Innocan Pharma
Aethlon Medical
ExoCoBio
Organicell
Puretech
Versatope
Vesvigen Therapeutics
Exosome Plus
Exosome Diagnostics
ECHO Biaotech
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Exosome Therapeutics and Diagnostics Market Size 2019-2030
2.1.2 Exosome Therapeutics and Diagnostics Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Exosome Therapeutics and Diagnostics by Country/Region, 2019, 2023 & 2030
2.2 Exosome Therapeutics and Diagnostics Segment by Type
2.2.1 Treatment
2.2.2 Diagnosis
2.3 Exosome Therapeutics and Diagnostics Market Size by Type
2.3.1 Exosome Therapeutics and Diagnostics Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Exosome Therapeutics and Diagnostics Market Size Market Share by Type (2019-2024)
2.4 Exosome Therapeutics and Diagnostics Segment by Application
2.4.1 Cancer
2.4.2 Neurological Diseases
2.4.3 Others
2.5 Exosome Therapeutics and Diagnostics Market Size by Application
2.5.1 Exosome Therapeutics and Diagnostics Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Exosome Therapeutics and Diagnostics Market Size Market Share by Application (2019-2024)
3 Exosome Therapeutics and Diagnostics Market Size by Player
3.1 Exosome Therapeutics and Diagnostics Market Size Market Share by Player
3.1.1 Global Exosome Therapeutics and Diagnostics Revenue by Player (2019-2024)
3.1.2 Global Exosome Therapeutics and Diagnostics Revenue Market Share by Player (2019-2024)
3.2 Global Exosome Therapeutics and Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Exosome Therapeutics and Diagnostics by Region
4.1 Exosome Therapeutics and Diagnostics Market Size by Region (2019-2024)
4.2 Global Exosome Therapeutics and Diagnostics Annual Revenue by Country/Region (2019-2024)
4.3 Americas Exosome Therapeutics and Diagnostics Market Size Growth (2019-2024)
4.4 APAC Exosome Therapeutics and Diagnostics Market Size Growth (2019-2024)
4.5 Europe Exosome Therapeutics and Diagnostics Market Size Growth (2019-2024)
4.6 Middle East & Africa Exosome Therapeutics and Diagnostics Market Size Growth (2019-2024)
5 Americas
5.1 Americas Exosome Therapeutics and Diagnostics Market Size by Country (2019-2024)
5.2 Americas Exosome Therapeutics and Diagnostics Market Size by Type (2019-2024)
5.3 Americas Exosome Therapeutics and Diagnostics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Exosome Therapeutics and Diagnostics Market Size by Region (2019-2024)
6.2 APAC Exosome Therapeutics and Diagnostics Market Size by Type (2019-2024)
6.3 APAC Exosome Therapeutics and Diagnostics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Exosome Therapeutics and Diagnostics Market Size by Country (2019-2024)
7.2 Europe Exosome Therapeutics and Diagnostics Market Size by Type (2019-2024)
7.3 Europe Exosome Therapeutics and Diagnostics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Exosome Therapeutics and Diagnostics by Region (2019-2024)
8.2 Middle East & Africa Exosome Therapeutics and Diagnostics Market Size by Type (2019-2024)
8.3 Middle East & Africa Exosome Therapeutics and Diagnostics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Exosome Therapeutics and Diagnostics Market Forecast
10.1 Global Exosome Therapeutics and Diagnostics Forecast by Region (2025-2030)
10.1.1 Global Exosome Therapeutics and Diagnostics Forecast by Region (2025-2030)
10.1.2 Americas Exosome Therapeutics and Diagnostics Forecast
10.1.3 APAC Exosome Therapeutics and Diagnostics Forecast
10.1.4 Europe Exosome Therapeutics and Diagnostics Forecast
10.1.5 Middle East & Africa Exosome Therapeutics and Diagnostics Forecast
10.2 Americas Exosome Therapeutics and Diagnostics Forecast by Country (2025-2030)
10.2.1 United States Market Exosome Therapeutics and Diagnostics Forecast
10.2.2 Canada Market Exosome Therapeutics and Diagnostics Forecast
10.2.3 Mexico Market Exosome Therapeutics and Diagnostics Forecast
10.2.4 Brazil Market Exosome Therapeutics and Diagnostics Forecast
10.3 APAC Exosome Therapeutics and Diagnostics Forecast by Region (2025-2030)
10.3.1 China Exosome Therapeutics and Diagnostics Market Forecast
10.3.2 Japan Market Exosome Therapeutics and Diagnostics Forecast
10.3.3 Korea Market Exosome Therapeutics and Diagnostics Forecast
10.3.4 Southeast Asia Market Exosome Therapeutics and Diagnostics Forecast
10.3.5 India Market Exosome Therapeutics and Diagnostics Forecast
10.3.6 Australia Market Exosome Therapeutics and Diagnostics Forecast
10.4 Europe Exosome Therapeutics and Diagnostics Forecast by Country (2025-2030)
10.4.1 Germany Market Exosome Therapeutics and Diagnostics Forecast
10.4.2 France Market Exosome Therapeutics and Diagnostics Forecast
10.4.3 UK Market Exosome Therapeutics and Diagnostics Forecast
10.4.4 Italy Market Exosome Therapeutics and Diagnostics Forecast
10.4.5 Russia Market Exosome Therapeutics and Diagnostics Forecast
10.5 Middle East & Africa Exosome Therapeutics and Diagnostics Forecast by Region (2025-2030)
10.5.1 Egypt Market Exosome Therapeutics and Diagnostics Forecast
10.5.2 South Africa Market Exosome Therapeutics and Diagnostics Forecast
10.5.3 Israel Market Exosome Therapeutics and Diagnostics Forecast
10.5.4 Turkey Market Exosome Therapeutics and Diagnostics Forecast
10.6 Global Exosome Therapeutics and Diagnostics Forecast by Type (2025-2030)
10.7 Global Exosome Therapeutics and Diagnostics Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Exosome Therapeutics and Diagnostics Forecast
11 Key Players Analysis
11.1 Evox Therapeutics
11.1.1 Evox Therapeutics Company Information
11.1.2 Evox Therapeutics Exosome Therapeutics and Diagnostics Product Offered
11.1.3 Evox Therapeutics Exosome Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Evox Therapeutics Main Business Overview
11.1.5 Evox Therapeutics Latest Developments
11.2 Carmine Therapeutics
11.2.1 Carmine Therapeutics Company Information
11.2.2 Carmine Therapeutics Exosome Therapeutics and Diagnostics Product Offered
11.2.3 Carmine Therapeutics Exosome Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Carmine Therapeutics Main Business Overview
11.2.5 Carmine Therapeutics Latest Developments
11.3 Exopharm
11.3.1 Exopharm Company Information
11.3.2 Exopharm Exosome Therapeutics and Diagnostics Product Offered
11.3.3 Exopharm Exosome Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Exopharm Main Business Overview
11.3.5 Exopharm Latest Developments
11.4 Aruna Bio
11.4.1 Aruna Bio Company Information
11.4.2 Aruna Bio Exosome Therapeutics and Diagnostics Product Offered
11.4.3 Aruna Bio Exosome Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Aruna Bio Main Business Overview
11.4.5 Aruna Bio Latest Developments
11.5 Capricor Therapeutics
11.5.1 Capricor Therapeutics Company Information
11.5.2 Capricor Therapeutics Exosome Therapeutics and Diagnostics Product Offered
11.5.3 Capricor Therapeutics Exosome Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Capricor Therapeutics Main Business Overview
11.5.5 Capricor Therapeutics Latest Developments
11.6 Mantra Bio
11.6.1 Mantra Bio Company Information
11.6.2 Mantra Bio Exosome Therapeutics and Diagnostics Product Offered
11.6.3 Mantra Bio Exosome Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Mantra Bio Main Business Overview
11.6.5 Mantra Bio Latest Developments
11.7 Adipomics
11.7.1 Adipomics Company Information
11.7.2 Adipomics Exosome Therapeutics and Diagnostics Product Offered
11.7.3 Adipomics Exosome Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Adipomics Main Business Overview
11.7.5 Adipomics Latest Developments
11.8 ReNeuron
11.8.1 ReNeuron Company Information
11.8.2 ReNeuron Exosome Therapeutics and Diagnostics Product Offered
11.8.3 ReNeuron Exosome Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 ReNeuron Main Business Overview
11.8.5 ReNeuron Latest Developments
11.9 Aegle Therapeutics
11.9.1 Aegle Therapeutics Company Information
11.9.2 Aegle Therapeutics Exosome Therapeutics and Diagnostics Product Offered
11.9.3 Aegle Therapeutics Exosome Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Aegle Therapeutics Main Business Overview
11.9.5 Aegle Therapeutics Latest Developments
11.10 Sarepta Therapeutics
11.10.1 Sarepta Therapeutics Company Information
11.10.2 Sarepta Therapeutics Exosome Therapeutics and Diagnostics Product Offered
11.10.3 Sarepta Therapeutics Exosome Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Sarepta Therapeutics Main Business Overview
11.10.5 Sarepta Therapeutics Latest Developments
11.11 Codiak Biosciences
11.11.1 Codiak Biosciences Company Information
11.11.2 Codiak Biosciences Exosome Therapeutics and Diagnostics Product Offered
11.11.3 Codiak Biosciences Exosome Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Codiak Biosciences Main Business Overview
11.11.5 Codiak Biosciences Latest Developments
11.12 Exosomics
11.12.1 Exosomics Company Information
11.12.2 Exosomics Exosome Therapeutics and Diagnostics Product Offered
11.12.3 Exosomics Exosome Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Exosomics Main Business Overview
11.12.5 Exosomics Latest Developments
11.13 Innocan Pharma
11.13.1 Innocan Pharma Company Information
11.13.2 Innocan Pharma Exosome Therapeutics and Diagnostics Product Offered
11.13.3 Innocan Pharma Exosome Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Innocan Pharma Main Business Overview
11.13.5 Innocan Pharma Latest Developments
11.14 Aethlon Medical
11.14.1 Aethlon Medical Company Information
11.14.2 Aethlon Medical Exosome Therapeutics and Diagnostics Product Offered
11.14.3 Aethlon Medical Exosome Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Aethlon Medical Main Business Overview
11.14.5 Aethlon Medical Latest Developments
11.15 ExoCoBio
11.15.1 ExoCoBio Company Information
11.15.2 ExoCoBio Exosome Therapeutics and Diagnostics Product Offered
11.15.3 ExoCoBio Exosome Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 ExoCoBio Main Business Overview
11.15.5 ExoCoBio Latest Developments
11.16 Organicell
11.16.1 Organicell Company Information
11.16.2 Organicell Exosome Therapeutics and Diagnostics Product Offered
11.16.3 Organicell Exosome Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Organicell Main Business Overview
11.16.5 Organicell Latest Developments
11.17 Puretech
11.17.1 Puretech Company Information
11.17.2 Puretech Exosome Therapeutics and Diagnostics Product Offered
11.17.3 Puretech Exosome Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Puretech Main Business Overview
11.17.5 Puretech Latest Developments
11.18 Versatope
11.18.1 Versatope Company Information
11.18.2 Versatope Exosome Therapeutics and Diagnostics Product Offered
11.18.3 Versatope Exosome Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Versatope Main Business Overview
11.18.5 Versatope Latest Developments
11.19 Vesvigen Therapeutics
11.19.1 Vesvigen Therapeutics Company Information
11.19.2 Vesvigen Therapeutics Exosome Therapeutics and Diagnostics Product Offered
11.19.3 Vesvigen Therapeutics Exosome Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 Vesvigen Therapeutics Main Business Overview
11.19.5 Vesvigen Therapeutics Latest Developments
11.20 Exosome Plus
11.20.1 Exosome Plus Company Information
11.20.2 Exosome Plus Exosome Therapeutics and Diagnostics Product Offered
11.20.3 Exosome Plus Exosome Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.20.4 Exosome Plus Main Business Overview
11.20.5 Exosome Plus Latest Developments
11.21 Exosome Diagnostics
11.21.1 Exosome Diagnostics Company Information
11.21.2 Exosome Diagnostics Exosome Therapeutics and Diagnostics Product Offered
11.21.3 Exosome Diagnostics Exosome Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.21.4 Exosome Diagnostics Main Business Overview
11.21.5 Exosome Diagnostics Latest Developments
11.22 ECHO Biaotech
11.22.1 ECHO Biaotech Company Information
11.22.2 ECHO Biaotech Exosome Therapeutics and Diagnostics Product Offered
11.22.3 ECHO Biaotech Exosome Therapeutics and Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
11.22.4 ECHO Biaotech Main Business Overview
11.22.5 ECHO Biaotech Latest Developments
12 Research Findings and Conclusion